Almost two decades ago, the existence of a subset of essential hyperte
nsive patients, who were sensitive (according to the increase in blood
pressure levels) to the intake of a diet with a high salt content, wa
s described. These patients are characterized by an increase in blood
pressure and in body weight when switched from a low to a high sodium
intake. The increase in body weight is due to the incapacity of the ki
dneys to excrete the whole intake of sodium until renal perfusion pres
sure (mean blood pressure) attains a level that is able to restore pre
ssure-natriuresis relationship to values that enable the kidney to exc
rete the salt ingested or administered intravenously. Salt sensitivity
does not seem to depend on the existence of an intrinsic renal defect
to handle sodium, but on the existence of subtle abnormalities in the
regulation of the sympathetic nervous system, the renin-angiotensin s
ystem or endothelial function. It is also relevant that organ damage s
econdary to arterial hypertension, has been shown in animal models and
in hypertensive humans sensitive to a high salt intake to be signific
antly higher when compared with that of salt-resistant animals or huma
ns. Interestingly, in humans, salt sensitivity has been shown to corre
late with microalbuminuria, an important predictor of cardiovascular m
orbidity and mortality, which correlates with most of the cardiovascul
ar risk factors commonly associated with arterial hypertension. One of
these factors is insulin resistance, that usually accompanies high bl
ood pressure in overweight and obese hypertensives. Insulin resistance
and hyperinsulinism are present in a significant percentage of hypert
ensive patients developing cardiovascular symptoms or death. For these
reasons, therapy of arterial hypertension must be directed, not only
to facilitate the lowering of BP level, but also, to halt the mechanis
ms underlying the increase in BP, when salt intake is increased. Furth
ermore, therapy must preferably improve the diminished insulin sensiti
vity present in salt-sensitive subjects that contribute independently
to increased cardiovascular risk. (C) 1998 Elsevier Science Ireland Lt
d. All rights reserved.